Mardi C. Dier's most recent trade in Madrigal Pharmaceuticals Inc was a trade of 1,183 Common Stock done at an average price of $427.2 . Disclosure was reported to the exchange on March 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Madrigal Pharma Inc | Mardi C. Dier | EVP and CFO | Sale of securities on an exchange or to another person at price $ 427.21 per share. | 02 Mar 2026 | 1,183 | 9,257 (0%) | 0% | 427.2 | 505,389 | Common Stock |
| ORIC Pharma Inc | Mardi C. Dier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Madrigal Pharma Inc | Mardi C. Dier | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 251.63 per share. | 02 Dec 2025 | 4,173 | 14,613 (0%) | 0% | 251.6 | 1,050,052 | Common Stock |
| Madrigal Pharma Inc | Mardi C. Dier | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2025 | 4,173 | 9,180 | - | - | Stock Option (Right to Buy) | |
| Madrigal Pharma Inc | Mardi C. Dier | EVP and CFO | Sale of securities on an exchange or to another person at price $ 574.00 per share. | 02 Dec 2025 | 717 | 12,812 (0%) | 0% | 574.0 | 411,559 | Common Stock |
| Madrigal Pharma Inc | Mardi C. Dier | EVP and CFO | Sale of securities on an exchange or to another person at price $ 579.85 per share. | 02 Dec 2025 | 480 | 11,394 (0%) | 0% | 579.9 | 278,329 | Common Stock |
| Madrigal Pharma Inc | Mardi C. Dier | EVP and CFO | Sale of securities on an exchange or to another person at price $ 571.99 per share. | 02 Dec 2025 | 410 | 13,883 (0%) | 0% | 572.0 | 234,516 | Common Stock |
| Madrigal Pharma Inc | Mardi C. Dier | EVP and CFO | Sale of securities on an exchange or to another person at price $ 573.01 per share. | 02 Dec 2025 | 354 | 13,529 (0%) | 0% | 573.0 | 202,847 | Common Stock |
| Madrigal Pharma Inc | Mardi C. Dier | EVP and CFO | Sale of securities on an exchange or to another person at price $ 577.82 per share. | 02 Dec 2025 | 320 | 12,132 (0%) | 0% | 577.8 | 184,901 | Common Stock |
| Madrigal Pharma Inc | Mardi C. Dier | EVP and CFO | Sale of securities on an exchange or to another person at price $ 570.39 per share. | 02 Dec 2025 | 320 | 14,293 (0%) | 0% | 570.4 | 182,524 | Common Stock |
| Madrigal Pharma Inc | Mardi C. Dier | EVP and CFO | Sale of securities on an exchange or to another person at price $ 578.83 per share. | 02 Dec 2025 | 258 | 11,874 (0%) | 0% | 578.8 | 149,338 | Common Stock |
| Madrigal Pharma Inc | Mardi C. Dier | EVP and CFO | Sale of securities on an exchange or to another person at price $ 587.85 per share. | 02 Dec 2025 | 240 | 10,914 (0%) | 0% | 587.9 | 141,084 | Common Stock |
| Madrigal Pharma Inc | Mardi C. Dier | EVP and CFO | Sale of securities on an exchange or to another person at price $ 585.44 per share. | 02 Dec 2025 | 240 | 11,154 (0%) | 0% | 585.4 | 140,505 | Common Stock |
| Madrigal Pharma Inc | Mardi C. Dier | EVP and CFO | Sale of securities on an exchange or to another person at price $ 576.15 per share. | 02 Dec 2025 | 240 | 12,452 (0%) | 0% | 576.2 | 138,276 | Common Stock |
| Madrigal Pharma Inc | Mardi C. Dier | EVP and CFO | Sale of securities on an exchange or to another person at price $ 590.38 per share. | 02 Dec 2025 | 160 | 10,594 (0%) | 0% | 590.4 | 94,460 | Common Stock |
| Madrigal Pharma Inc | Mardi C. Dier | EVP and CFO | Sale of securities on an exchange or to another person at price $ 589.65 per share. | 02 Dec 2025 | 160 | 10,754 (0%) | 0% | 589.7 | 94,344 | Common Stock |
| Madrigal Pharma Inc | Mardi C. Dier | EVP and CFO | Sale of securities on an exchange or to another person at price $ 574.95 per share. | 02 Dec 2025 | 120 | 12,692 (0%) | 0% | 575.0 | 68,994 | Common Stock |
| Madrigal Pharma Inc | Mardi C. Dier | EVP and CFO | Sale of securities on an exchange or to another person at price $ 596.19 per share. | 02 Dec 2025 | 80 | 10,440 (0%) | 0% | 596.2 | 47,695 | Common Stock |
| Madrigal Pharma Inc | Mardi C. Dier | EVP and CFO | Sale of securities on an exchange or to another person at price $ 595.20 per share. | 02 Dec 2025 | 74 | 10,520 (0%) | 0% | 595.2 | 44,045 | Common Stock |
| Prelude Therapeutics Inc | Mardi C. Dier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 38,000 | 38,000 | - | - | Director Stock Option (Right to Buy) | |
| Madrigal Pharma Inc | Mardi C. Dier | SVP and CFO | Sale of securities on an exchange or to another person at price $ 323.04 per share. | 10 Mar 2025 | 258 | 10,440 (0%) | 0% | 323.0 | 83,344 | Common Stock |
| Madrigal Pharma Inc | Mardi C. Dier | SVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 6,374 | 6,374 | - | - | Stock Option (Right to Buy) | |
| Madrigal Pharma Inc | Mardi C. Dier | SVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 3,784 | 10,698 (0%) | 0% | 0 | Common Stock | |
| Madrigal Pharma Inc | Mardi C. Dier | SVP and CFO | Sale of securities on an exchange or to another person at price $ 325.89 per share. | 03 Mar 2025 | 1,187 | 7,688 (0%) | 0% | 325.9 | 386,831 | Common Stock |
| Madrigal Pharma Inc | Mardi C. Dier | SVP and CFO | Sale of securities on an exchange or to another person at price $ 323.54 per share. | 03 Mar 2025 | 774 | 6,914 (0%) | 0% | 323.5 | 250,417 | Common Stock |
| ORIC Pharma Inc | Mardi C. Dier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Prelude Therapeutics Inc | Mardi C. Dier | Director | 14 Jun 2024 | 23,500 | 23,500 | - | - | Director Stock Option (Right to Buy) | ||
| ORIC Pharma Inc | Mardi C. Dier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 25,600 | 25,600 | - | - | Stock Option (right to buy) | |
| Prelude Therapeutics Inc | Mardi C. Dier | Director | 16 Jun 2023 | 23,500 | 23,500 | - | - | Director Stock Option (Right to Buy) | ||
| ORIC Pharma Inc | Mardi C. Dier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 20,500 | 20,500 | - | - | Stock Option (right to buy) | |
| Acelyrin Inc | Mardi C. Dier | CFO and CBO | Other type of transaction at price $ 0.00 per share. | 09 May 2023 | 673,621 | 0 | - | - | Employee Stock Option (right to buy) | |
| Acelyrin Inc | Mardi C. Dier | CFO and CBO | Other type of transaction at price $ 0.00 per share. | 09 May 2023 | 673,621 | 673,621 | - | - | Employee Stock Option (right to buy) | |
| Acelyrin Inc | Mardi C. Dier | CFO and CBO | Other type of transaction at price $ 0.00 per share. | 09 May 2023 | 85,226 | 85,226 | - | - | Employee Stock Option (right to buy) | |
| Acelyrin Inc | Mardi C. Dier | CFO and CBO | Other type of transaction at price $ 0.00 per share. | 09 May 2023 | 85,226 | 0 | - | - | Employee Stock Option (right to buy) | |
| Acelyrin Inc | Mardi C. Dier | CFO and CBO | Purchase of securities on an exchange or from another person at price $ 18.00 per share. | 09 May 2023 | 5,556 | 5,556 | - | 18 | 100,008 | Common Stock |
| Acelyrin Inc | Mardi C. Dier | CFO and CBO | Purchase of securities on an exchange or from another person at price $ 18.00 per share. | 09 May 2023 | 875 | 875 | - | 18 | 15,750 | Common Stock |
| Acelyrin Inc | Mardi C. Dier | CFO and CBO | Purchase of securities on an exchange or from another person at price $ 18.00 per share. | 09 May 2023 | 875 | 875 | - | 18 | 15,750 | Common Stock |
| Acelyrin Inc | Mardi C. Dier | CFO and CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2023 | 85,226 | 85,226 | - | - | Employee Stock Option (right to buy) | |
| Ultragenyx Pharmaceutical Inc | Mardi C. Dier | CFO & Executive Vice President | Sale of securities on an exchange or to another person at price $ 40.16 per share. | 14 Oct 2022 | 1,629 | 66,695 (0%) | 0% | 40.2 | 65,421 | Common Stock |
| Ultragenyx Pharmaceutical Inc | Mardi C. Dier | CFO & Executive Vice President | Sale of securities on an exchange or to another person at price $ 38.22 per share. | 12 Oct 2022 | 3,484 | 68,324 (0%) | 0% | 38.2 | 133,158 | Common Stock |
| Ultragenyx Pharmaceutical Inc | Mardi C. Dier | CFO & Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2022 | 20,000 | 71,808 (0%) | 0% | 0 | Common Stock | |
| Prelude Therapeutics Inc | Mardi C. Dier | Director | 17 Jun 2022 | 34,300 | 34,300 | - | - | Director Stock Option (Right to Buy) | ||
| Ultragenyx Pharmaceutical Inc | Mardi C. Dier | CFO & Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 24,900 | 24,900 | - | - | Stock Option (Right to Buy) | |
| Ultragenyx Pharmaceutical Inc | Mardi C. Dier | CFO & Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 14,000 | 52,228 (0%) | 0% | 0 | Common Stock | |
| Ultragenyx Pharmaceutical Inc | Mardi C. Dier | CFO & Executive Vice President | Sale of securities on an exchange or to another person at price $ 66.62 per share. | 01 Mar 2022 | 534 | 38,228 (0%) | 0% | 66.6 | 35,575 | Common Stock |
| Ultragenyx Pharmaceutical Inc | Mardi C. Dier | CFO & Executive Vice President | Sale of securities on an exchange or to another person at price $ 64.55 per share. | 01 Mar 2022 | 420 | 51,808 (0%) | 0% | 64.6 | 27,111 | Common Stock |
| Ultragenyx Pharmaceutical Inc | Mardi C. Dier | CFO & Executive Vice President | Sale of securities on an exchange or to another person at price $ 82.79 per share. | 12 Oct 2021 | 3,477 | 42,023 (0%) | 0% | 82.8 | 287,861 | Common Stock |
| Ultragenyx Pharmaceutical Inc | Mardi C. Dier | CFO & Executive Vice President | Sale of securities on an exchange or to another person at price $ 81.16 per share. | 12 Oct 2021 | 3,261 | 38,762 (0%) | 0% | 81.2 | 264,663 | Common Stock |
| Prelude Therapeutics Inc | Mardi C. Dier | Director | 18 Jun 2021 | 23,344 | 23,344 | - | - | Director Stock Option (Right to Buy) | ||
| ORIC Pharma Inc | Mardi C. Dier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 16,625 | 16,625 | - | - | Stock Option (right to buy) |